Suppr超能文献

[通腑泄肺法治疗急性呼吸窘迫综合征的系统评价与Meta分析]

[A systematic review and Meta-analysis of Tongfu Xiefei method in the treatment of acute respiratory distress syndrome].

作者信息

Cheng Lu, Zhang Yan, He Shuyin, Zhuang Yan, Lyu Hai, Pei Yinghao, Zhou Jiang, Lu Jun

机构信息

Department of Critical Care Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing 210029, Jiangsu, China. Corresponding author: Lu Jun, Email:

出版信息

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Aug;32(8):970-975. doi: 10.3760/cma.j.cn121430-20200506-00361.

Abstract

OBJECTIVE

To systematically review the effect of Tongfu Xiefei method on prognosis and respiratory mechanics parameters in patients with acute respiratory distress syndrome (ARDS).

METHODS

The randomized controlled trials (RCT) of Tongfu Xiefei method for ARDS published on PubMed, Web of Science, Embase, CNKI and Wanfang database from January 1st 2001 to June 30th 2019 were searched. Conventional treatment for ARDS that included mechanical ventilation, prone ventilation, anti-infection, organ function maintenance and nutritional therapy were used in the control group. While the Tongfu Xiefei method was applied in the experimental group based on the conventional treatment. The main outcome was in-hospital mortality, and the secondary outcomes included mechanic ventilation time, length of intensive care unit (ICU) stay and respiratory mechanics parameters. Two researchers independently searched the literature, collected data and assessed the risk of bias. The bias risk assessment was completed by RevMan 5.3 software. The Meta-analysis was completed by R software. The potential publication bias of main outcome was evaluation.

RESULTS

A total of 27 RCTs were included. There were 1 763 patients, including 899 in the experimental group and 864 in the control group. Meta-analysis showed that, compared with the control group, the in-hospital mortality of the experimental group significantly decreased [relative risk (RR) = 0.46, 95% confidence interval (95%CI) was 0.36 to 0.59, P < 0.000 1], the mechanic ventilation time and the length of ICU stay were significantly shortened [mechanical ventilation time: standard mean difference (SMD) = -1.92, 95%CI was -2.56 to -1.29, P < 0.000 1; length of ICU stay: SMD = -1.84, 95%CI was -2.49 to -1.18, P < 0.000 1], oxygenation index was significantly improved (SMD = 2.26, 95%CI was 1.56 to 2.96, P < 0.000 1), airway peak pressure, airway platform pressure, mean airway pressure and airway resistance significantly decreased (airway peak pressure: SMD = -1.26, 95%CI was -2.35 to -0.18, P = 0.021 8; airway platform pressure: SMD = -0.61, 95%CI was -1.08 to -0.14, P = 0.010 7; mean airway pressure: SMD = - 1.67, 95%CI was - 2.93 to -0.42, P = 0.009 1; airway resistance: SMD = -0.88, 95%CI was -1.09 to -0.67, P < 0.000 1), while lung compliance increased (SMD = 1.57, 95%CI was 0.78 to 2.36, P < 0.000 1). The results of publication bias assessment showed that there was no potential publication bias (P = 0.499).

CONCLUSIONS

Tongfu Xiefei method is capable of reducing the in-hospital mortality, shortening the mechanical ventilation time and the length of ICU stay, and improving respiratory mechanics parameters for patients with ARDS.

摘要

目的

系统评价通腑泄肺法对急性呼吸窘迫综合征(ARDS)患者预后及呼吸力学参数的影响。

方法

检索2001年1月1日至2019年6月30日在PubMed、Web of Science、Embase、中国知网和万方数据库上发表的关于通腑泄肺法治疗ARDS的随机对照试验(RCT)。对照组采用ARDS的常规治疗,包括机械通气、俯卧位通气、抗感染、器官功能维持和营养治疗。而实验组在常规治疗的基础上应用通腑泄肺法。主要结局为住院死亡率,次要结局包括机械通气时间、重症监护病房(ICU)住院时间和呼吸力学参数。两名研究人员独立检索文献、收集数据并评估偏倚风险。采用RevMan 5.3软件完成偏倚风险评估。采用R软件完成Meta分析。对主要结局的潜在发表偏倚进行评估。

结果

共纳入27项RCT。有1763例患者,其中实验组899例,对照组864例。Meta分析显示,与对照组相比,实验组的住院死亡率显著降低[相对危险度(RR)=0.46,95%置信区间(95%CI)为0.36至0.59,P<0.0001],机械通气时间和ICU住院时间显著缩短[机械通气时间:标准均差(SMD)=-1.92,95%CI为-2.56至-1.29,P<0.0001;ICU住院时间:SMD=-1.84,95%CI为-2.49至-1.18,P<0.0001],氧合指数显著改善(SMD=2.26,95%CI为1.56至2.96,P<0.0001),气道峰压、气道平台压、平均气道压和气道阻力显著降低(气道峰压:SMD=-1.26,95%CI为-2.35至-0.18,P=0.0218;气道平台压:SMD=-0.61,95%CI为-1.08至-0.14,P=0.0107;平均气道压:SMD=-1.67,95%CI为-2.93至-0.42,P=0.0091;气道阻力:SMD=-0.88,95%CI为-1.09至-0.67,P<0.0001),而肺顺应性增加(SMD=1.57,95%CI为0.78至2.36,P<0.0001)。发表偏倚评估结果显示无潜在发表偏倚(P=0.499)。

结论

通腑泄肺法能够降低ARDS患者的住院死亡率,缩短机械通气时间和ICU住院时间,并改善呼吸力学参数。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验